Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro

Abstract

BACKGROUND Canine oral fibrosarcoma (COF) is one of the most common oral tumors in dogs and carries a guarded prognosis due to a lack of effective systemic therapeutic options. Mastinib and imatinib are two commonly used tyrosine kinase inhibitors (TKIs) in veterinary oncology but their potential efficacy against COF is uncharacterized. To begin… (More)
DOI: 10.1186/s12917-016-0712-x

Topics

11 Figures and Tables

Cite this paper

@inproceedings{Milovancev2016AntiproliferativeEO, title={Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro}, author={Milan Milovancev and Stuart C. Helfand and Kevin Marley and Cheri P. Goodall and Christiane V L{\"o}hr and Shay Bracha}, booktitle={BMC veterinary research}, year={2016} }